Literature DB >> 1127603

Evaluation of nuclear-substituted styryl ketones and related compounds for antitumor and cytotoxic properties.

J R Dimmock, W G Taylor.   

Abstract

A number of nuclear-substituted styryl ketones, the related Mannich bases, and allyl alcohols were synthesized and evaluated for antitumor activity, principally in the L-1210 lymphoid leukemia and P-388 lymphocytic leukemia screening tests. The cytotoxicity of some of these compounds assessed in Eagle's 9KB carcinoma cell culture system was also recorded. Two of the Mannich bases showed promising levels of activity in the P-388 screening; of the results obtained to date, over one-third of the derivatives showed cytotoxicity at dose levels of 1-3 ppm. Other pharmacological results of these compounds are briefly reported.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1127603     DOI: 10.1002/jps.2600640210

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

1.  Cytotoxic 2-benzylidene-6-(nitrobenzylidene)cyclohexanones which display substantially greater toxicity for neoplasms than non-malignant cells.

Authors:  Umashankar Das; Alireza Doroudi; H Inci Gul; Hari N Pati; Masami Kawase; Hiroshi Sakagami; Qing Chu; James P Stables; Jonathan R Dimmock
Journal:  Bioorg Med Chem       Date:  2010-02-04       Impact factor: 3.641

Review 2.  1,5-diaryl-3-oxo-1,4-pentadienes: a case for antineoplastics with multiple targets.

Authors:  U Das; R K Sharma; J R Dimmock
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

3.  Novel 3,5-bis(arylidene)-4-oxo-1-piperidinyl dimers: structure-activity relationships and potent antileukemic and antilymphoma cytotoxicity.

Authors:  Yahaira Santiago-Vazquez; Swagatika Das; Umashankar Das; Elisa Robles-Escajeda; Nora M Ortega; Carolina Lema; Armando Varela-Ramírez; Renato J Aguilera; Jan Balzarini; Erik De Clercq; Stephen G Dimmock; Dennis K J Gorecki; Jonathan R Dimmock
Journal:  Eur J Med Chem       Date:  2014-03-06       Impact factor: 6.514

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.